In a thread discussing sarcopenia therapies, it was noted that SS-31 (Elamipretide) has shown promising findings in clinical research for muscle-related disorders. While noted as an effective mitochondrial targeting agent, the forum contributor emphasized that it has not yet received official approval for the treatment of sarcopenia.